A non-invasive blood glucose measurement device and multianalyte sensing tool will compete for $50,000 against two yet-to-be-announced teams in the finals of the Healthcare Innovation World Cup next month.
The two finalists were named at the international diabetes challenge’s regional semifinal event in New Delhi, India on Friday, April 26. Competing against four other teams from throughout Africa, Asia and the Middle East, innovators earned their places by demonstrating impact on solving unmet needs in diabetes care, as well as innovation, feasibility and financial sustainability of their ideas.
Finalists from Africa, Asia and the Middle East are:
Team IITKgp is developing a non-invasive blood glucose measurement device, based on photoacoustic spectroscopy, to enable painless, sample-free and accurate glucose measurement for diabetics. A photoacoustic measurement apparatus has been constructed, and the system has been verified in vitro on glucose solutions. Initial measurements performed on tissue have provided an accuracy of nearly 70% compared to reference measurements. Additionally, the team is developing a portable prototype device for wide-scale use and commercialization. IITKgp operates on the campus of the Indian Institute of Technology Kharagpur.
SmartSense’s creation is a multianalyte sensing device for diabetic ketoacidosis (DKA). With a single prick, the device can sense all the metabolites necessary for management of the condition. According to team members, it is designed to reduce the pain and economic burden faced by patients with DKA. The SmartSense team is based in the department of biosciences and bioengineering the Indian Institute of Technology Bombay.
Both finalist teams received $2,500 in awards, and now will prepare to travel to New York, USA for the final competition on Friday, May 10. Two more finalists from Europe and the Americas will be named at a second regional semifinal on Thursday, May 9.
For more information, please visit www.healthcareinnovationworldcup.com